Searched for
IMMUNOLOGY DRUGS
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Overhaul of drug regulator begins with recruitment plan for 1,500 specialistsIndia's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Biocon rolls out two biosimilars in US marketBiocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...
- ACC clears Dr Rajeev Singh Raghuvanshi’s reappointment as Drugs Controller (India)Dr Rajeev Singh Raghuvanshi will continue as Drugs Controller (India) at CDSCO. His reappointment is on a contract basis for one year start...
- Eli Lilly bets on next-generation cell therapy with $2.4 billion deal for OrnaEli Lilly will buy Orna Therapeutics for up to $2.4 billion in cash, gaining access to a technology that allows patients' own cells to gen...
- Sanofi buys US biopharma group Blueprint in $9.1 billion dealSanofi is set to acquire Blueprint Medicines for $9.1 billion, strengthening its immunology portfolio with the addition of Ayvakit/Ayvakyt,...
- Nvidia, Pfizer lead $80 million funding for Israeli medical AI tech firm CytoReasonCytoReason raised $80 million from Nvidia, Pfizer, Thermo Fisher, and OurCrowd to expand its AI models and open a Cambridge office. Their P...
- Rajeev Raghuvanshi appointed as new Drug Controller General of IndiaOn November 11, last year, Dr VG Somani's term as DCGI was extended for three months, for the second time, coming into effect on November 1...
- UPSC recommends Rajeev Singh Raghuvanshi as next DCGIThe UPSC recommendation has to be approved by the Health Ministry, followed by approval of the Appointments Committee of Cabinet led by Pri...
- Hester Biosciences to roll out Covaxin drug substance by April 2022Ahmedabad-based Hester Biosciences is a part of Gujarat Covid Vaccine Consortium (GCVC), which in May this year signed an agreement with Bh...
- IIL to make 10 million doses of Covaxin drug substance from DecemberIndian Immunologicals' Managing Director K Anand Kumar informed that IIL is also working on an attenuated COVID-19 vaccine which is likely ...
- Indian Immunologiclas to start drug substance production for Covaxin from JuneManaging Director K Anand Kumar in a release on Friday said the firm is expected to produce the drug substance initially for 2-3 million do...
- Bharat Biotech ties up with IIL for Covaxin materialHyderabad-based IIL, part of the NDDB, said it will send out the first batch of the drug ingredient to Bharat Biotech by July.
- AstraZeneca shares sink 8% after $39 billion Alexion buyoutChief Executive Officer Pascal Soriot had told reporters on Saturday that the deal, a bet on rare-disease and immunology drugs, was the res...
- NIH and DBT to review vaccine candidates for Covid-19 this weekThe meeting will see research groups and vaccine developers funded through India-US tieups present their progress on Covid-19 vaccines and ...
- COVID-19: 16 companies get funds for R&D workThe department of biotechnology has granted funds to 16 companies for developing drugs, vaccines and devices to fight the Covid-19 pandemic...
- Biocon teams up with Sandoz for next-gen BiosimilarsBiosimilars are identical copies of highly complex biologic drugs that are said to have the same efficacy.
- Indian Immunologicals to unveil feed for lab animals used for clinical trialsAt present, India houses hundreds of scientific bodies, both in public and private sectors, which together have nearly 10 million lab anima...
Load More
